Elevance Health (ELV) Shares Outstanding (2009 - 2026)

Elevance Health (ELV) has 18 years of Shares Outstanding data on file, last reported at $217.4 million in Q1 2026.

• Quarterly Shares Outstanding fell 3.68% year-over-year to $217.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $217.4 million (down 3.68% YoY) and the FY2025 annual result came in at $220.7 million, down 2.98% from the prior year.
• Shares Outstanding slipped to $217.4 million in Q1 2026 per ELV's latest filing, from $220.7 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $241.1 million in Q1 2022 and bottomed at $217.4 million in Q1 2026.
• The 5-year median for Shares Outstanding is $232.5 million (2024), against an average of $231.4 million.
• The widest annual swing landed in 2024, when Shares Outstanding dropped 1.28%; it then decreased 4.25% in 2025.
• Tracing ELV's Shares Outstanding over 5 years: stood at $238.0 million in 2022, then slipped by 2.06% to $233.1 million in 2023, then dropped by 2.4% to $227.5 million in 2024, then dropped by 2.98% to $220.7 million in 2025, then declined by 1.51% to $217.4 million in 2026.
• Per Business Quant, the three latest ELV Shares Outstanding figures stand at $217.4 million (Q1 2026), $220.7 million (Q4 2025), and $222.0 million (Q3 2025).

Peer Comparison